Diffuse Lung Disease
-
Study explores geographic disparities in tobacco dependence treatment among veterans with COPD
Study author Arianne K. Baldomero, MD, said that reducing geographic barriers will require multidisciplinary approaches and innovative, equitable health care solutions.
-
Closing the gap in pulmonary rehabilitation
If pulmonary rehabilitation in the United States is going to meet the scale of need in coming years, it must grow consistently, equitably, and sustainably.
-
Panelists address local approaches for clean air and climate action
Stephanie Lovinsky-Desir, MD, MS, presented on the health effects and mitigation of pollutant exposures at or near schools.
-
Sarcoidosis experts review decisions from diagnosis to transplant
Hakim Azfar Ali, MD, MPH, FCCP, discussed indications and timing for lung transplantation referral in patients with sarcoidosis.
-
Session addresses complex pulmonary vascular challenges in cirrhosis
Yu Kuang (Julie) Lai, MD, detailed the diagnosis of hepatopulmonary syndrome and post-liver transplant hypoxemia during the session, which also reviewed portopulmonary hypertension.
-
Radiologists, pulmonologists to discuss identification of interstitial lung abnormalities
Joe Mammarappallil, MD, PhD, will chair a Monday afternoon session on the recognition and risk stratification of ILAs, including how to differentiate imaging red herrings from findings that point toward progressive fibrosis.
-
90th anniversary sessions to reflect on past, present, and future of field
Nichole T. Tanner, MD, MSCR, FCCP, and five other CHEST experts will chair special sessions about 90 years of progress in mechanical ventilation, TB, lung cancer, diffuse lung disease, respiratory vaccines, and asthma.
-
Panel to outline growing impact of climate change in critical care
Stephanie Maximous, MD, MS, will chair a Sunday morning session on climate change’s growing encroachments in critical illness and acute conditions such as heart attacks, strokes, and asthma exacerbations.
-
Speakers to discuss crucial distinctions of familial, sporadic ILDs
Mary Beth Scholand, MD, FCCP, will serve as co-chair of a Sunday afternoon session on current practices in assessing familial and sporadic ILD patients with telomere measurements and genetic testing.
-
Lung transplantation experts to discuss growing possibilities for patients
Anupam Kumar, MD, FCCP, will chair a Wednesday session on controversies and opportunities that have emerged in the field of lung transplantation in recent years.
-
CHEST grant recipient reflects on completed project in streamlining ILD diagnoses
With her project complete, Kavitha Selvan, MD, shares how the quality improvement grant from CHEST through the Bridging Specialties®: Timely Diagnosis for ILD program has impacted patient care, affected providers, and supported her growth as a clinician.
-
Study identifies key environmental exposures associated with risk of interstitial lung disease
Bradford C. Bemiss, MD, MSc, said the findings underscore the importance of asking patients about potential workplace inhalation exposures.
